Skip to main content
. Author manuscript; available in PMC: 2017 Jan 24.
Published in final edited form as: Circulation. 2015 Dec 3;133(3):273–281. doi: 10.1161/CIRCULATIONAHA.115.018830

Table 2.

Proportion of CRT patients receiving CRT-D compared to CRT-P device, stratified by age group

% CRT-D
Age 18-74 (n=157,258) Age ≥75 (n=100,643) Difference, % (95% CI)
Overall 90.8 79.3 11.6 (8.5 to 12.6)
Type of admission
    Elective 91.2 81.7 9.3 (8.2 to 10.5)
    Acute 90.5 76.6 13.7 (12.4 to 15.1)
Cardiac history
    Ventricular arrhythmia 96.5 92.1 4.4 (3.5 to 5.2)
    Ischemic heart disease 93.2 83.3 9.9 (9.0 to 10.9)
    Atrial fibrillation 84.6 73.3 11.3 (10.1 to 12.6)
    Complete AV block 72.7 65.9 6.8 (4.3 to 9.3)
Elixhauser comorbidities*
    0 90.3 82.0 8.3 (6.8 to 9.7)
    1-2 91.5 80.1 11.4 (10.3 to 12.6)
    3-4 90.4 77.2 13.2 (11.7 to 14.8)
    ≥5 89.1 75.5 13.6 (11.2 to 16.0)
Heart failure comorbidities
    0 90.2 77.8 12.4 (10.3 to 14.6)
    1-2 90.9 78.7 12.2 (11.0 to 13.5)
    3-4 90.4 80.6 10.6 (9.4 to 11.8)
    ≥5 89.2 79.9 9.3 (6.3 to 12.3)
*

Measures 28 comorbidities of the Elixhauser index.14

Measures seven comorbidities associated with high mortality rate and reduced ICD efficacy among heart failure patients: ischemic heart disease, atrial fibrillation, diabetes, chronic lung disease, chronic kidney disease, peripheral vascular disease, and smoking.15

‡All comparisons between age 18-74 and age ≥75 had p<0.05.